Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:30-35

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Côté, G.
Right arrow Articles by Crépeau, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Côté, G.
Right arrow Articles by Crépeau, J.
Related Collections
Right arrow Remodeling
Right arrow Restenosis
Right arrow Coronary imaging: angiography/ultrasound/Doppler/CC

(Circulation. 1999;99:30-35.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Effects of Probucol on Vascular Remodeling After Coronary Angioplasty

Gilles Côté, MD; Jean-Claude Tardif, MD; Jacques Lespérance, MD; Jean Lambert, PhD; Martial Bourassa, MD; Raoul Bonan, MD; Gilbert Gosselin, MD; Michel Joyal, MD; Jean-François Tanguay, MD; Stanley Nattel, MD; Richard Gallo, MD; Jacques Crépeau, MD; for the Multivitamins and Probucol Study Group

From the Department of Medicine, Montreal Heart Institute, Montreal, Canada.

Correspondence to Jean-Claude Tardif, MD, Director, Intravascular Ultrasound Laboratory, Montreal Heart Institute, 5000 Belanger St, Montreal, Canada H1T 1C8. E-mail tardifjc{at}icm.umontreal.ca

Background—We have shown that probucol reduces restenosis after balloon angioplasty. Whether probucol acted via prevention of neointimal formation or improvement in vascular remodeling could not be addressed by angiography and required the use of intravascular ultrasound (IVUS).

Methods and Results—Beginning 30 days before angioplasty, 317 patients were randomly assigned to receive probucol, multivitamins, combined treatment, or placebo. Patients were then treated for 6 months after angioplasty. IVUS examination was performed immediately after angioplasty and at follow-up in 94 patients (111 segments). The cross section selected for serial analysis was the one at the angioplasty site with the smallest lumen area at follow-up. In the placebo group, lumen area decreased by -1.21±1.88 mm2 at follow-up, and wall area and external elastic membrane (EEM) area increased by 1.50±2.50 and 0.29±2.93 mm2, respectively. Change in lumen area, however, correlated more strongly with the change in EEM area (r=0.53, P=0.002) than with the change in wall area (r=-0.13, P=0.49). Lumen loss was -1.21±1.88 mm2 for placebo, -0.83±1.22 mm2 for vitamins, -0.25±1.17 mm2 for combined treatment, and -0.15±1.70 mm2 for probucol alone (P=0.002 for probucol, P=0.84 for vitamins). Change in wall area was similar for all groups. EEM area increased by 0.29±2.93 mm2 for placebo, 0.09±2.33 mm2 for vitamins only, 1.17±1.61 mm2 for combined treatment, and 1.74±1.80 mm2 for probucol only (P=0.005 for probucol).

Conclusions—Lumen loss after balloon angioplasty is due to inadequate vessel remodeling in response to neointimal formation. Probucol exerts its antirestenotic effects by improving vascular remodeling after angioplasty.


Key Words: antioxidants • coronary disease • restenosis • angioplasty • ultrasonics • remodeling




This article has been cited by other articles:


Home page
Eur Heart JHome page
R. A. Byrne, J. Mehilli, R. Iijima, S. Schulz, J. Pache, M. Seyfarth, A. Schomig, A. Kastrati, and for the Intracoronary Stenting and Angiographic Re
A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents
Eur. Heart J., April 2, 2009; 30(8): 923 - 931.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J.-C. Tardif, J. Gregoire, P. L. L'Allier, R. Ibrahim, J. Lesperance, T. M. Heinonen, S. Kouz, C. Berry, R. Basser, M.-A. Lavoie, et al.
Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary Atherosclerosis: A Randomized Controlled Trial
JAMA, April 18, 2007; 297(15): 1675 - 1682.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
V. Serebruany, A. Malinin, and R. Scott
The In Vitro Effects of a Novel Vascular Protectant, AGI-1067, on Platelet Aggregation and Major Receptor Expression in Subjects With Multiple Risk Factors for Vascular Disease.
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2006; 11(3): 191 - 196.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
R. S. Schwartz, N. A. Chronos, and R. Virmani
Preclinical restenosis models and drug-eluting stents: Still important, still much to learn
J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1373 - 1385.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y.-M. Deng, B. J. Wu, P. K. Witting, and R. Stocker
Probucol Protects Against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1
Circulation, September 28, 2004; 110(13): 1855 - 1860.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
J.-C. Tardif, J. Gregoire, P.L. Lallier, and M. Joyal
Chronic heart rate reduction with ivabradine and prevention of atherosclerosis progression assessed using intravascular ultrasound
Eur. Heart J. Suppl., September 1, 2003; 5(suppl_G): G46 - G51.
[Abstract] [PDF]


Home page
CirculationHome page
A. K. Lau, S. B. Leichtweis, P. Hume, R. Mashima, J. Y. Hou, X. Chaufour, B. Wilkinson, N. H. Hunt, D. S. Celermajer, and R. Stocker
Probucol Promotes Functional Reendothelialization in Balloon-Injured Rabbit Aortas
Circulation, April 22, 2003; 107(15): 2031 - 2036.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. M. Gotto Jr
Antioxidants, statins, and atherosclerosis
J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1205 - 1210.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-C. Tardif, J. Gregoire, L. Schwartz, L. Title, L. Laramee, F. Reeves, J. Lesperance, M. G. Bourassa, P. L. L'Allier, M. Glass, et al.
Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions
Circulation, February 4, 2003; 107(4): 552 - 558.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. G. Brown, M. C. Cheung, A. C. Lee, X.-Q. Zhao, and A. Chait
Antioxidant Vitamins and Lipid Therapy: End of a Long Romance?
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1535 - 1546.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M A Costa, K Kozuma, A L Gaster, W J van der Giessen, M Sabaté, D P Foley, I P Kay, J M R Ligthart, P Thayssen, M J van den Brand, et al.
Three dimensional intravascular ultrasonic assessment of the local mechanism of restenosis after balloon angioplasty
Heart, January 1, 2001; 85(1): 73 - 79.
[Abstract] [Full Text]


Home page
CirculationHome page
M. R. Ward, G. Pasterkamp, A. C. Yeung, and C. Borst
Arterial Remodeling : Mechanisms and Clinical Implications
Circulation, September 5, 2000; 102(10): 1186 - 1191.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. C.P. Azevedo, M. d. A. Pedro, L. C. Souza, H. P. de Souza, M. Janiszewski, P. L. da Luz, and F. R.M. Laurindo
Oxidative stress as a signaling mechanism of the vascular response to injury: The redox hypothesis of restenosis
Cardiovasc Res, August 18, 2000; 47(3): 436 - 445.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Mavromatis, T. Fukai, M. Tate, N. Chesler, D. N. Ku, and Z. S. Galis
Early Effects of Arterial Hemodynamic Conditions on Human Saphenous Veins Perfused Ex Vivo
Arterioscler Thromb Vasc Biol, August 1, 2000; 20(8): 1889 - 1895.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Meerkin, J.-C. Tardif, O. F. Bertrand, J. Vincent, F. Harel, and R. Bonan
The effects of intracoronary brachytherapy on the natural history of postangioplasty dissections
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. W. Serruys, D. P. Foley, B. Hofling, J. Puel, H. D. Glogar, R. Seabra-Gomes, J. Goicolea, P. Coste, W. Rutsch, H. Katus, et al.
Carvedilol for Prevention of Restenosis After Directional Coronary Atherectomy : Final Results of the European Carvedilol Atherectomy Restenosis (EUROCARE) Trial
Circulation, April 4, 2000; 101(13): 1512 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. J. Wiegman, W. L. Barry, J. A. McPherson, C. A. McNamara, L. W. Gimple, J. M. Sanders, G. G. Bishop, E. R. Powers, M. Ragosta, G. K. Owens, et al.
All-trans-Retinoic Acid Limits Restenosis After Balloon Angioplasty in the Focally Atherosclerotic Rabbit : A Favorable Effect on Vessel Remodeling
Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 89 - 95.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Lafont, E. Durand, J. L. Samuel, B. Besse, F. Addad, B. I. Levy, M. Desnos, C. Guerot, and C. M. Boulanger
Endothelial Dysfunction and Collagen Accumulation : Two Independent Factors for Restenosis and Constrictive Remodeling After Experimental Angioplasty
Circulation, September 7, 1999; 100(10): 1109 - 1115.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Meerkin, J.-C. Tardif, I. R. Crocker, A. Arsenault, M. Joyal, G. Lucier, S. B. King III, D. O. Williams, P. W. Serruys, and R. Bonan
Effects of Intracoronary ß-Radiation Therapy After Coronary Angioplasty : An Intravascular Ultrasound Study
Circulation, April 6, 1999; 99(13): 1660 - 1665.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. J. Sierevogel, E. Velema, P. P. de Jaegere, D. P. de Kleijn, C. Borst, and G. Pasterkamp
Minimal Duration of Oral Matrix Metalloproteinase Inhibition to Prevent Constrictive Arterial Remodeling after Balloon Dilation in the Pig
Radiology, February 1, 2002; 222(2): 468 - 473.
[Abstract] [Full Text] [PDF]